Literature DB >> 17210626

Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease.

H M M Smeding1, A E Goudriaan, E M J Foncke, P R Schuurman, J D Speelman, B Schmand.   

Abstract

We describe a patient with advanced Parkinson's disease who developed pathological gambling within a month after successful bilateral subthalamic nucleus (STN) stimulation. There was no history of gambling. On neuropsychological testing, slight cognitive decline was evident 1 year after surgery. Stimulation of the most dorsal contact with and without medication induced worse performances on decision making tests compared with the more ventral contact. Pathological gambling disappeared after discontinuation of pergolide and changing the stimulation parameters. Pathological gambling does not seem to be associated with decision making but appears to be related to a combination of bilateral STN stimulation and treatment with dopamine agonists.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17210626      PMCID: PMC2117849          DOI: 10.1136/jnnp.2006.102061

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

1.  Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation.

Authors:  Claire Ardouin; Valerie Voon; Yulia Worbe; Nehman Abouazar; Virginie Czernecki; Hassan Hosseini; Antoine Pelissolo; Elena Moro; Eugénie Lhommée; Anthony E Lang; Yves Agid; Alim-Louis Benabid; Pierre Pollak; Luc Mallet; Paul Krack
Journal:  Mov Disord       Date:  2006-11       Impact factor: 10.338

2.  Decision making in pathological gambling: a comparison between pathological gamblers, alcohol dependents, persons with Tourette syndrome, and normal controls.

Authors:  Anna E Goudriaan; Jaap Oosterlaan; Edwin de Beurs; Wim van den Brink
Journal:  Brain Res Cogn Brain Res       Date:  2005-04

3.  Clinical features associated with impulse control disorders in Parkinson disease.

Authors:  Gregory Pontone; James R Williams; Susan Spear Bassett; Laur Marsh
Journal:  Neurology       Date:  2006-10-10       Impact factor: 9.910

4.  Effect on mood of subthalamic DBS for Parkinson's disease: a consecutive series of 24 patients.

Authors:  A Berney; F Vingerhoets; A Perrin; P Guex; J-G Villemure; P R Burkhard; C Benkelfat; J Ghika
Journal:  Neurology       Date:  2002-11-12       Impact factor: 9.910

5.  Mania following deep brain stimulation for Parkinson's disease.

Authors:  J Kulisevsky; M L Berthier; A Gironell; B Pascual-Sedano; J Molet; P Parés
Journal:  Neurology       Date:  2002-11-12       Impact factor: 9.910

6.  Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment?

Authors:  J A Molina; M J Sáinz-Artiga; A Fraile; F J Jiménez-Jiménez; C Villanueva; M Ortí-Pareja; F Bermejo
Journal:  Mov Disord       Date:  2000-09       Impact factor: 10.338

7.  Impulsivity predicts problem gambling in low SES adolescent males.

Authors:  F Vitaro; L Arseneault; R E Tremblay
Journal:  Addiction       Date:  1999-04       Impact factor: 6.526

8.  Behavioural disorders, Parkinson's disease and subthalamic stimulation.

Authors:  J L Houeto; V Mesnage; L Mallet; B Pillon; M Gargiulo; S Tezenas du Moncel; A M Bonnet; B Pidoux; D Dormont; P Cornu; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

9.  Insensitivity to future consequences following damage to human prefrontal cortex.

Authors:  A Bechara; A R Damasio; H Damasio; S W Anderson
Journal:  Cognition       Date:  1994 Apr-Jun

10.  Decision-making impairments in patients with Parkinson's disease.

Authors:  Matthias Brand; Kirsten Labudda; Elke Kalbe; Rüdiger Hilker; David Emmans; Gerd Fuchs; Josef Kessler; Hans J Markowitsch
Journal:  Behav Neurol       Date:  2004       Impact factor: 3.342

View more
  60 in total

1.  Long-term follow-up of impulse control disorders in Parkinson's disease.

Authors:  Eugenia Mamikonyan; Andrew D Siderowf; John E Duda; Marc N Potenza; Stacy Horn; Matthew B Stern; Daniel Weintraub
Journal:  Mov Disord       Date:  2008-01       Impact factor: 10.338

Review 2.  Parkinson's disease: the quintessential neuropsychiatric disorder.

Authors:  Daniel Weintraub; David J Burn
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

Review 3.  Impulsivity and Parkinson's disease: more than just disinhibition.

Authors:  Francesca Antonelli; Nicola Ray; Antonio P Strafella
Journal:  J Neurol Sci       Date:  2011-06-17       Impact factor: 3.181

4.  Betting on DBS: Effects of subthalamic nucleus deep brain stimulation on risk taking and decision making in patients with Parkinson's disease.

Authors:  Jason Brandt; Mark Rogerson; Haya Al-Joudi; Gila Reckess; Barnett Shpritz; Chizoba C Umeh; Noha Aljehani; Kelly Mills; Zoltan Mari
Journal:  Neuropsychology       Date:  2014-12-08       Impact factor: 3.295

Review 5.  New pharmacological and neuromodulation approaches for impulsive-compulsive behaviors in Parkinson's disease.

Authors:  Giacomo Grassi; Giovanni Albani; Federica Terenzi; Lorenzo Razzolini; Silvia Ramat
Journal:  Neurol Sci       Date:  2021-04-14       Impact factor: 3.307

Review 6.  Deep Brain Stimulation Emergencies: How the New Technologies Could Modify the Current Scenario.

Authors:  Giovanni Cossu; Mariachiara Sensi
Journal:  Curr Neurol Neurosci Rep       Date:  2017-07       Impact factor: 5.081

Review 7.  Deep brain stimulation for the treatment of drug addiction.

Authors:  Tony R Wang; Shayan Moosa; Robert F Dallapiazza; W Jeffrey Elias; Wendy J Lynch
Journal:  Neurosurg Focus       Date:  2018-08       Impact factor: 4.047

8.  The Influence of Bilateral Subthalamic Nucleus Deep Brain Stimulation on Impulsivity and Prepulse Inhibition in Parkinson's Disease Patients.

Authors:  Lucy Gee; Heather Smith; Priscilla De La Cruz; Joannalee Campbell; Chris Fama; Jessica Haller; Adolfo Ramirez-Zamora; Jennifer Durphy; Era Hanspal; Eric Molho; Anne Barba; Damian Shin; Julie G Pilitsis
Journal:  Stereotact Funct Neurosurg       Date:  2015-06-10       Impact factor: 1.875

Review 9.  Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.

Authors:  Sean S O'Sullivan; Andrew H Evans; Andrew J Lees
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 10.  Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.

Authors:  Barbara Connolly; Susan H Fox
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.